Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis
Publication in refereed journal


Full Text

Times Cited
Web of Science49WOS source URL (as at 07/08/2020) Click here for the latest count

Other information
AbstractThe diagnosis of HBV reactivation during cytotoxic chemotherapy is based on an abrupt rise in levels of serum HBV DNA in conjunction with a hepatitic picture and in the absence of other causes of hepatitis. However, several cases of "hepatitis" have been noted during chemotherapy in HBsAg-positive patients, for which no cause could be found and in which HBV DNA levels were negative. One possible explanation is that HBV reactivation may, indeed, have been the cause but that HBV DNA levels became negative by the time ALT levels peaked and the clinical diagnosis of hepatitis was made. During the course of a longitudinal study of HBsAg-seropositive cancer patients who were monitored during standard chemotherapy, the opportunity was available to test this hypothesis. (C) 2001 Wiley-Liss, Inc.
All Author(s) ListYeo W, Chan PKS, Chan HLY, Mo FKF, Johnson PJ
Journal nameJournal of Medical Virology
Year2001
Month11
Day1
Volume Number65
Issue Number3
PublisherWILEY-BLACKWELL
Pages473 - 477
ISSN0146-6615
eISSN1096-9071
LanguagesEnglish-United Kingdom
Keywordshepatitis B virus; immunosuppression; reactivation
Web of Science Subject CategoriesVirology; VIROLOGY

Last updated on 2020-08-08 at 02:21